Details of Lassa Virus Structure Could Inform Development of Vaccines, Therapies
Published:09 Jun.2017    Source:National Institutes of Health

A 10-year Lassa virus research project has yielded structural and functional details of a key viral surface protein that could help advance development of Lassa vaccines and antibody-based therapeutics, which are currently lacking.

The work was led by the Scripps Research Institute (TSRI) and funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.